Psychiatry Research: Neuroimaging
Volume 174, Issue 3 , Pages 171-176 , 30 December 2009

Lower glutamate levels in rostral anterior cingulate of chronic cocaine users — A 1H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy

  • Shaolin Yang

      Affiliations

    • Neuroimaging Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • ,
  • Betty Jo Salmeron

      Affiliations

    • Neuroimaging Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • ,
  • Thomas J. Ross

      Affiliations

    • Neuroimaging Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • ,
  • Zheng-Xiong Xi

      Affiliations

    • Chemical Biology Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • ,
  • Elliot A. Stein

      Affiliations

    • Neuroimaging Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • ,
  • Yihong Yang

      Affiliations

    • Neuroimaging Research Branch, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, MD 21224, USA
    • Corresponding Author InformationCorresponding author. Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, 251 Bayview Blvd, Suite 200, Room 07A709, Baltimore, MD 21224, USA. Tel.: +1 443 740 2648; fax: +1 443 740 2816.

Received 23 May 2008 ,Revised 24 February 2009 ,Accepted 18 May 2009.

References 

  1. Adalsteinsson E, Hurd RE, Mayer D, Sailasuta N, Sullivan EV, Pfefferbaum A. In vivo 2D J-resolved magnetic resonance spectroscopy of rat brain with a 3-T clinical human scanner. Neuroimage. 2004;22:381–386
  2. Adalsteinsson E, Sullivan EV, Mayer D, Pfefferbaum A. In vivo quantification of ethanol kinetics in rat brain. Neuropsychopharmacology. 2006;31:2683–2691
  3. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, et al. Neuroadaptations in cystine–glutamate exchange underlie cocaine relapse. Nature Neuroscience. 2003;6:743–749
  4. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory—II. San Antonio, TX: Psychological Corporation; 1996;
  5. Chang L, Ernst T, Strickland T, Mehringer CM. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. American Journal of Psychiatry. 1999;156:716–722
  6. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry. 1999;156:11–18
  7. Choi C, Coupland NJ, Bhardwaj PP, Kalra S, Casault CA, Reid K, et al. T(2) measurement and quantification of glutamate in human brain in vivo. Magnetic Resonance in Medicine. 2006;56:971–977
  8. de Graaf RA, Mason GF, Patel AB, Rothman DL, Behar KL. Regional glucose metabolism and glutamatergic neurotransmission in rat brain in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:12700–12705
  9. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biological Psychiatry. 2002;51:134–142
  10. Gallinat J, Schubert F. Regional cerebral glutamate concentrations and chronic tobacco consumption. Pharmacopsychiatry. 2007;40:64–67
  11. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry. 2002;159:1642–1652
  12. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine. 2000;13:129–153
  13. Hancu I, Zimmerman EA, Sailasuta N, Hurd RE. 1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease. Magnetic Resonance in Medicine. 2005;53:777–782
  14. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3 T. Magnetic Resonance in Medicine. 2004;51:435–440
  15. Kalivas PW. Neurobiology of cocaine addiction: implications for new pharmacotherapy. American Journal on Addictions. 2007;16:71–78
  16. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry. 2005;162:1403–1413
  17. Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO–NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience. 2003;23:7839–7843
  18. Kickler N, Krack P, Fraix V, Lebas JF, Lamalle L, Durif F, et al. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. NMR in Biomedicine. 2007;20:757–762
  19. Li SJ, Wang Y, Pankiewicz J, Stein EA. Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers. Biological Psychiatry. 1999;45:1481–1487
  20. Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2007;31:389–394
  21. Meyerhoff DJ, Bloomer C, Schuff N, Ezekiel F, Norman D, Clark W, et al. Cortical metabolite alterations in abstinent cocaine and cocaine/alcohol-dependent subjects: proton magnetic resonance spectroscopic imaging. Addiction Biology. 1999;4:405–419
  22. O'Neill J, Cardenas VA, Meyerhoff DJ. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addiction Biology. 2001;6:347–361
  23. Peoples LL. Neuroscience. Will, anterior cingulate cortex, and addiction. Science. 2002;296:1623–1624
  24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  25. Sailasuta, N., Ernst, T., Chang, L., 2008. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magnetic Resonance Imaging 26 (5), 667–675.
  26. Sanacora G, Rothman DL, Mason G, Krystal JH. Clinical studies implementing glutamate neurotransmission in mood disorders. Annals of the New York Academy of Sciences. 2003;1003:292–308
  27. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage. 2004;21:1762–1771
  28. Shen J, Petersen KF, Behar KL, Brown P, Nixon TW, Mason GF, et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:8235–8240
  29. Smith SA, Levante TO, Meier BH, Ernst RR. Computer simulations in magnetic resonance. An object-oriented programming approach. Journal of Magnetic Resonance, Series A. 1994;106:75–105
  30. Smith JE, Koves TR, Co C. Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration. Neuroscience. 2003;117:461–475
  31. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain. 2005;128:1016–1025
  32. Stein E, Gu H, Ross T, Salmeron B, Yang Y. Reduced functional connectivity in cocaine users revealed by resting-state functional MRI. Neuropsychopharmacology. 2006;31:S201–S202
  33. Thomas MJ, Beurrier C, Bonci A, Malenka RC. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nature Neuroscience. 2001;4:1217–1223
  34. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14:169–177
  35. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26:479–488
  36. Yang S, Hu J, Kou Z, Yang Y. Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4 T. Magnetic Resonance in Medicine. 2008;59:236–244
  37. Zhang Y, Marenco S, Shen J. Correction of frequency and phase variations induced by eddy currents in localized spectroscopy with multiple echo times. Magnetic Resonance in Medicine. 2007;58:174–178

PII: S0925-4927(09)00140-1

doi: 10.1016/j.pscychresns.2009.05.004

Psychiatry Research: Neuroimaging
Volume 174, Issue 3 , Pages 171-176 , 30 December 2009

Article Tools

* Image Usage & Resolution